Mutagenic Activity of Cyclophosphamide, Ifosfamide, and Trofosfamide in Different Genes of Escherichia Coli and Salmonella Typhimurium After Biotransformation Through Extracts of Rodent Liver

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 1975 Jan 1

PMID 1096853

Citations 10

Authors

J Ellenberger

G Mohn

Affiliations

Soon will be listed here.

Abstract

Experiments are performed to compare the mutagenic properties of the three phosphamide esters of nitrogen mustard, cyclophosphamide (CP), ifosfamide (IF), and trofosfamide (TF), in different bacterial systems. The systems include forward mutations leading to resistance against 5-methyltryptophan (MTR) and from galR-s18 to gal-+ in Escherichia coli 343/113, back mutations from arg56 to arg-+ in Escherichia coli 343/113 and back mutations from hisG46 to his-+ in Salmonella typhimurium TA1535. CP, IF, and TF are not mutagenic per se. After biotransformation through isolated rodent liver homogenates (S-9 fraction) all three compounds exhibit mutagenic activity in the order CP smaller than IF smaller than TF. Specific activating potential of mouse liver extracts is higher than that of rat liver. Except for back mutations in S. typhimurium TA1535, all mutation systems tested show a similar pattern of induction after treatment with CP, IF, and TF. However, because gal-+ mutations are not induced by CP under conditions where arg-+ and MTR are induced, it is suggested that more than one mutational system be used in routine mutagenicity testing.

Citing Articles

Pharmaceutical Transformation Products Formed by Ozonation-Does Degradation Occur?.

Zilberman A, Gozlan I, Avisar D Molecules. 2023; 28(3).

PMID: 36770894 PMC: 9919501. DOI: 10.3390/molecules28031227.

Modeling kinetics of subcellular disposition of chemicals.

Balaz S Chem Rev. 2009; 109(5):1793-899.

PMID: 19265398 PMC: 2682929. DOI: 10.1021/cr030440j.

Correction method for estimating the number of reversions in bacteria.

rihova E Folia Microbiol (Praha). 1981; 26(5):426-9.

PMID: 7319403 DOI: 10.1007/BF02927340.

Appreciation of the value of different bacterial test systems for detecting and for ranking chemical mutagens.

Mohn G, Ellenberger J Arch Toxicol. 1980; 46(1-2):45-60.

PMID: 7235998 DOI: 10.1007/BF00361245.

Forward mutation in Escherichia coli and gene conversion in Saccharomyces cerevisiae compared quantitatively with reversion in Salmonella typhimurium.

Mitchell I Agents Actions. 1980; 10(3):287-95.

PMID: 6996463 DOI: 10.1007/BF02025949.

References

Hill D, Laster Jr W, Kirk M, STRUCK R . Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite. Cancer Res. 1973; 33(5):1016-22. View

Cohen J, Jao J . Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. J Pharmacol Exp Ther. 1970; 174(2):206-10. View

Torkelson A, LABUDDE J, WEIKEL Jr J . The metabolic fate of cyclophosphamide. Drug Metab Rev. 1974; 3(1):131-65. DOI: 10.3109/03602537408993740. View

UEHLEKE H . The formation and kinetics of reactive drug metabolites in mammals. Mutat Res. 1974; 25(2):159-67. DOI: 10.1016/0027-5107(74)90016-5. View

Hiraga S . Operator mutants of the tryptophan operon in Escherichia coli. J Mol Biol. 1969; 39(1):159-79. DOI: 10.1016/0022-2836(69)90340-4. View

Garner R, Miller E, Miller J, Garner J, Hanson R . Formation of a factor lethal for S. typhimurium TA1530 and TA1531 on incubation of aflatoxin B 1 with rat liver microsomes. Biochem Biophys Res Commun. 1971; 45(3):774-80. DOI: 10.1016/0006-291x(71)90484-0. View

Morse D, Yanofsky C . Amber mutants of the trpR regulatory gene. J Mol Biol. 1969; 44(1):185-93. DOI: 10.1016/0022-2836(69)90413-6. View

Mohn G, Ellenberger J, McGregor D . Development of mutagenicity test using Escherichia coli K-12 as indicator organism. Mutat Res. 1974; 25(2):187-96. DOI: 10.1016/0027-5107(74)90019-0. View

Fiethen L, Starlinger P . Mutations in the galactose-operator. Mol Gen Genet. 1970; 108(4):322-30. DOI: 10.1007/BF00267769. View

10.

Fahrig R . Metabolic activation of mutagens in mammals host-mediated assay utilizing the induction of mitotic gene conversion in Saccharomyces cerevisiae. Agents Actions. 1973; 3(2):99-110. DOI: 10.1007/BF01986541. View

11.

Neubert D . The toxicological evaluation of mutagenic events. Mutat Res. 1974; 25(2):145-57. DOI: 10.1016/0027-5107(74)90015-3. View

12.

Rosenkranz H . Aspects of microbiology in cancer research. Annu Rev Microbiol. 1973; 27:383-401. DOI: 10.1146/annurev.mi.27.100173.002123. View

13.

Mohn G, KAPLAN R . [Influencing the spontaneous and chemically induced mutability of E. coli through changing the genetic background]. Mol Gen Genet. 1967; 99(2):191-202. DOI: 10.1007/BF00426163. View

14.

Malling H, Frantz C . In vitro versus in vivo metabolic activation of mutagens. Environ Health Perspect. 1973; 6:71-82. PMC: 1475552. DOI: 10.1289/ehp.730671. View

15.

Hiraga S, Ito K, Hamada K, Yura T . A new regulatory gene for the tryptophan operon of Escherichia coli. Biochem Biophys Res Commun. 1967; 26(5):522-7. DOI: 10.1016/0006-291x(67)90095-2. View

16.

Moyed H . False feedback inhibition: inhibition of tryptophan biosynthesis by 5-methyltryptophan. J Biol Chem. 1960; 235:1098-102. View

17.

Mohn G . 5-Methyltryptophan resistance mutations in Escherichia coli K-12. Mutagenic activity of monofunctional alkylating agents including organophosphorus insecticides. Mutat Res. 1973; 20(1):7-15. DOI: 10.1016/0027-5107(73)90092-4. View

18.

Siebert D . A new method for testing genetically active metabolites. Urinary assay with cyclophosphamide (endoxan, cytoxan) and Saccharomyces cerevisiae. Mutat Res. 1973; 17(3):307-14. DOI: 10.1016/0027-5107(73)90002-x. View

19.

Siebert D . Comparison of the genetic activity of cyclophosphamide, ifosfamide and trofosfamide in host-mediated assays with the gene conversion system of yeast. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974; 81(3-4):261-7. DOI: 10.1007/BF00305028. View

20.

Connors T, Cox P, Farmer P, Foster A, Jarman M . Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol. 1974; 23(1):115-29. DOI: 10.1016/0006-2952(74)90318-9. View